InnovAge Holding Corp. revenue by segment INNV

Annual Quarterly

InnovAge Holding Corp. splits its revenue into 2 lines in its filings. The largest line in fiscal 2026, which ended Jun 30, 2026 was Capitation Revenue at $988.4 million, 100% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2027 Sep 30, 2026	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021
Revenue	1,018	990	854	764	688	699	638
Capitation Revenue	1,017 +15.2% share 99.9%	988 +16.0% share 99.9%	852 +11.8% share 99.8%	763 +11.0% share 99.8%	687 -1.5% share 99.8%	697 +9.7% share 99.8%	635 share 99.6%
Other Service Revenue	1 -23.7% share 0.1%	1 -1.7% share 0.1%	1 +4.7% share 0.2%	1 +2.7% share 0.2%	1 -23.8% share 0.2%	2 -33.7% share 0.2%	2 share 0.4%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Services-Health Services (SIC 8000)
Listed as: INNV (Nasdaq)
Fiscal year ends: June 30
Incorporated in: DE
Headquarters: Denver, CO
SEC filer status: Accelerated filer, Smaller reporting company
SEC CIK: 1834376
Former names: TCO GROUP HOLDINGS, INC. (until Jan 20, 2021)

Other Services-Health Services companies

All 17 Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.